# Clinical and molecular factors for selection of nivolumab or irinotecan as third-line treatment for advanced gastric cancer

> Research article (Therapeutic Advances in Medical Oncology, 2020) · cited 14× · AI/ML

**Wikidata**: [openalex:W3043356023](https://www.wikidata.org/wiki/openalex:W3043356023)  
**Source**: https://4ort.xyz/entity/clinical-and-molecular-factors-for-selection-of-nivolumab-or-irinotecan-as-third-line-treatment-for-advanced-gastric-can